PAPP-A may promote the development of atherosclerosis, plaque instability, and plaque rupture mainly through PAPP-A, IGFBP-4, and IGF-I/IGF-IR signal transduction systems, as well as interaction with other inflammatory cells and inflammatory factors (27). This evidence concerns the gene IGFBP4 and atherosclerosis.